Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erlichman

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Cancer Research|October 15, 1993
Phase I pharmacokinetic study of cyclosporin A combined with doxorubicinC Erlichman, M Moore, J J Thiessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeksS R Alberts, C Erlichman, J M Reid, et al.
Oncology|July 1, 1997
An evaluation of postoperative follow-up tests in colon cancer patients treated for cureP Peethambaram, M Weiss, C L Loprinzi, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapyD Osoba, C Erlichman, A R Willan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 1, 1991
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indicationJ R Skillings, M Levine, H L Rayner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factorR M Goldberg, J M Reid, M M Ames, et al.
Cancer Research|October 1, 1979
Phase I trial of N-(phosphonacetyl)-L-aspartateC Erlichman, J M Strong, P H Wiernik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566C Erlichman, A A Adjei, S R Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Cancer Research|October 15, 1993
Phase I pharmacokinetic study of cyclosporin A combined with doxorubicinC Erlichman, M Moore, J J Thiessen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 1998
Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeksS R Alberts, C Erlichman, J M Reid, et al.
Oncology|July 1, 1997
An evaluation of postoperative follow-up tests in colon cancer patients treated for cureP Peethambaram, M Weiss, C L Loprinzi, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1988
Failure of methylprednisolone acetate to prolong the antinauseant effect of intravenous methylprednisolone sodium succinate in patients receiving chemotherapyD Osoba, C Erlichman, A R Willan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 1, 1991
Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indicationJ R Skillings, M Levine, H L Rayner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factorR M Goldberg, J M Reid, M M Ames, et al.
Cancer Research|October 1, 1979
Phase I trial of N-(phosphonacetyl)-L-aspartateC Erlichman, J M Strong, P H Wiernik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566C Erlichman, A A Adjei, S R Alberts, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
A phase I study of sequential irinotecan and 5-fluorouracil/leucovorinR M Goldberg, S H Kaufmann, P Atherton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Pageof 10